BNP Paribas Financial Markets
CGON icon

BNP Paribas Financial Markets’s CG Oncology CGON Stock Holding History

BNP Paribas Financial Markets’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.31M Buy
108,039
+11,936
+12% +$676K ﹤0.01% 1758
2025
Q4 		$3.99M Buy
96,103
+84,428
+723% +$3.49M ﹤0.01% 2190
2025
Q3 		$470K Sell
11,675
-67,985
-85% -$1.98M ﹤0.01% 3576
2025
Q2 		$2.07M Buy
79,660
+75,881
+2,008% +$1.83M ﹤0.01% 2441
2025
Q1 		$92.5K Sell
3,779
-1,857
-33% -$52.2K ﹤0.01% 4063
2024
Q4 		$162K Sell
5,636
-21,024
-79% -$719K ﹤0.01% 3978
2024
Q3 		$1.01M Buy
26,660
+23,931
+877% +$839K ﹤0.01% 2498
2024
Q2 		$86.2K Sell
2,729
-8,469
-76% -$294K ﹤0.01% 3326
2024
Q1 		$492K Buy
+11,198
New +$457K ﹤0.01% 2852

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BNP Paribas Financial Markets's CGON Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its CG Oncology (CGON) stake by 12% in Q1 2026, buying an estimated $676K and bringing the position to 108,039 shares worth $7.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

BNP Paribas Financial Markets first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • BNP Paribas Financial Markets held 108,039 shares of CG Oncology worth $7.31M as of Q1 2026.
  • BNP Paribas Financial Markets bought 11,936 CG Oncology shares in Q1 2026, an estimated $676K.
  • CG Oncology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1758 holding.
  • BNP Paribas Financial Markets first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.